Xinhua Liu Selected Research

Mi-2 Nucleosome Remodeling and Deacetylase Complex

1/2022	BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer.
11/2020	The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
1/2018	Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinhua Liu Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 08/2005
13	Inflammation (Inflammations) 06/2022 - 05/2012
10	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2003
9	Carcinogenesis 09/2021 - 05/2009
8	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
7	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2007
7	Cognitive Dysfunction 01/2020 - 06/2005
5	Melanoma (Melanoma, Malignant) 01/2022 - 11/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2012
5	Asthma (Bronchial Asthma) 01/2017 - 07/2011
4	Wounds and Injuries (Trauma) 03/2022 - 12/2002
4	Stroke (Strokes) 01/2022 - 01/2014
4	Retinoblastoma (Glioblastoma, Retinal) 12/2021 - 06/2005
4	Birth Weight (Birth Weights) 10/2021 - 07/2012
4	Neoplasm Metastasis (Metastasis) 03/2021 - 10/2016
4	Body Weight (Weight, Body) 01/2021 - 04/2012
4	Dementia (Dementias) 01/2019 - 06/2005
4	Hyperhomocysteinemia 01/2017 - 06/2005
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2022 - 09/2018
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 01/2018
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Idiopathic Pulmonary Fibrosis 10/2020 - 09/2018
3	Myocardial Infarction 01/2020 - 01/2017
3	Infections 01/2020 - 02/2006
3	Chromosome Aberrations (Chromosome Abnormalities) 07/2012 - 02/2005
3	Substance-Related Disorders (Drug Abuse) 01/2011 - 10/2006
3	Alcoholism (Alcohol Abuse) 12/2006 - 04/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2020
2	Diabetes Mellitus 11/2021 - 09/2010
2	Liver Neoplasms (Liver Cancer) 01/2021 - 08/2005
2	Hypoxia (Hypoxemia) 01/2021 - 10/2019
2	Obesity 01/2021 - 01/2021
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 05/2019
2	Stomach Neoplasms (Stomach Cancer) 11/2020 - 04/2002
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2016
2	Hereditary Corneal Dystrophies 03/2020 - 01/2018
2	Colitis 01/2020 - 01/2019
2	Disease Progression 01/2020 - 01/2019
2	Pituitary ACTH Hypersecretion 01/2020 - 08/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2019
2	Rheumatoid Arthritis 01/2019 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2017
2	Tremor (Tremors) 01/2018 - 09/2013
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2016 - 02/2015

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 09/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
10	ArsenicIBA 01/2017 - 11/2006
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
7	leonurineIBA 08/2021 - 04/2012
7	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 06/2005
5	Biological ProductsIBA 01/2022 - 02/2011
5	Histone DemethylasesIBA 01/2020 - 01/2016
4	Histone MethyltransferasesIBA 02/2022 - 12/2021
4	Histones (Histone)IBA 01/2022 - 09/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2010
4	Therapeutic UsesIBA 08/2021 - 05/2012
4	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2006
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 02/2009
4	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 07/2015 - 02/2005
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2011 - 05/2007
3	CytokinesIBA 01/2022 - 06/2019
3	MethyltransferasesIBA 01/2022 - 01/2021
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2018
3	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 01/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 09/2021 - 01/2021
3	CarcinogensIBA 03/2021 - 07/2012
3	LipidsIBA 01/2021 - 01/2018
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 01/2018
3	Drinking WaterIBA 01/2017 - 09/2010
3	Cocaine (Cocaine HCl)IBA 10/2006 - 04/2002
2	Serine Proteases (Serine Protease)IBA 06/2022 - 01/2021
2	Cathepsin CIBA 06/2022 - 01/2021
2	LigandsIBA 01/2022 - 05/2007
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2021
2	Lysine (L-Lysine)FDA Link 01/2022 - 01/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 09/2018
2	Retinaldehyde (Retinal)IBA 12/2021 - 06/2005
2	NAD (NADH)IBA 11/2021 - 01/2021
2	CreatinineIBA 10/2021 - 02/2009
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 12/2019
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2020
2	F-Box ProteinsIBA 01/2021 - 01/2021
2	Caspase 9IBA 01/2021 - 01/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 05/2019
2	bushen jianpiIBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 11/2020 - 10/2015
2	Insulin (Novolin)FDA Link 01/2020 - 04/2012
2	NucleotidesIBA 01/2020 - 12/2012
2	InflammasomesIBA 01/2020 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2017
2	Ubiquitin-Specific ProteasesIBA 10/2018 - 01/2018
2	CateninsIBA 08/2018 - 10/2016
2	Apolipoproteins E (ApoE)IBA 01/2018 - 06/2005
2	AllergensIBA 01/2017 - 07/2016
2	BilirubinIBA 02/2016 - 02/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2006
3	Drug Therapy (Chemotherapy) 09/2021 - 10/2016
3	Activities of Daily Living (ADL) 01/2018 - 06/2011
2	Radiotherapy 03/2021 - 01/2016
2	Phacoemulsification 01/2018 - 12/2002